Cargando…
Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer
Aberrant methylation of CpG islands acquired in promoter regions plays an important role in carcinogenesis. Accumulated evidence demonstrates FHIT gene promoter hyper-methylation is involved in non-small cell lung cancer (NSCLC). To test the diagnostic ability of FHIT methylation status on NSCLC, th...
Autores principales: | Geng, Xin, Pu, Weilin, Tan, Yulong, Lu, Zhouyi, Wang, An, Tan, Lixing, Chen, Sidi, Guo, Shicheng, Wang, Jiucun, Chen, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351674/ https://www.ncbi.nlm.nih.gov/pubmed/28036263 http://dx.doi.org/10.18632/oncotarget.14256 |
Ejemplares similares
-
Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
por: Pu, Weilin, et al.
Publicado: (2016) -
Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer
por: Guo, Shicheng, et al.
Publicado: (2014) -
Genome-Wide DNA Methylation Profiles Reveal Common Epigenetic Patterns of Interferon-Related Genes in Multiple Autoimmune Diseases
por: Chen, Sidi, et al.
Publicado: (2019) -
Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han Population
por: Wang, Chenji, et al.
Publicado: (2018) -
Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)
por: Pu, Weilin, et al.
Publicado: (2017)